Figure S1 from RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy

Authors:

Abstract
Taselisib and GDC-0077 have increased potency in PIK3CA-mutant cancer cells